NasdaqGS - Delayed Quote • USD
Praxis Precision Medicines, Inc. (PRAX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:16 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,447.00
2,447.00
--
--
--
Operating Expense
128,820.00
128,820.00
214,986.00
167,332.00
61,968.00
Operating Income
-126,373.00
-126,373.00
-214,986.00
-167,332.00
-61,968.00
Net Non Operating Interest Income Expense
--
--
--
--
140.00
Other Income Expense
3,096.00
3,096.00
957.00
271.00
140.00
Pretax Income
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,828.00
Tax Provision
--
--
--
--
-8.00
Net Income Common Stockholders
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-70,323.00
Diluted NI Available to Com Stockholders
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-70,323.00
Basic EPS
-18.69
--
-69.65
-59.10
-117.90
Diluted EPS
-18.69
--
-69.65
-59.10
-117.90
Basic Average Shares
6,594.32
--
3,073.10
2,830.27
596.68
Diluted Average Shares
6,594.32
--
3,073.10
2,830.27
596.68
Total Operating Income as Reported
-126,373.00
-126,373.00
-214,986.00
-167,332.00
-61,968.00
Total Expenses
128,820.00
128,820.00
214,986.00
167,332.00
61,968.00
Net Income from Continuing & Discontinued Operation
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,820.00
Normalized Income
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,820.00
Interest Income
--
--
--
--
140.00
Net Interest Income
--
--
--
--
140.00
EBIT
-126,373.00
-126,373.00
-214,986.00
-167,332.00
-61,968.00
EBITDA
-125,941.00
-125,941.00
-214,567.00
-167,150.00
-61,918.00
Reconciled Depreciation
432.00
432.00
419.00
182.00
50.00
Net Income from Continuing Operation Net Minority Interest
-123,277.00
-123,277.00
-214,029.00
-167,061.00
-61,820.00
Normalized EBITDA
-125,941.00
-125,941.00
-214,567.00
-167,150.00
-61,918.00
Tax Rate for Calcs
--
--
--
--
0.00
12/31/2020 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRUS Merus N.V.
45.04
+0.24%
PCVX Vaxcyte, Inc.
60.72
+1.10%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
OLMA Olema Pharmaceuticals, Inc.
9.95
+1.22%
KALV KalVista Pharmaceuticals, Inc.
10.78
+2.76%
LXEO Lexeo Therapeutics, Inc.
12.50
+2.80%
CYTK Cytokinetics, Incorporated
65.34
+0.83%
CRNX Crinetics Pharmaceuticals, Inc.
42.12
-0.40%
IMVT Immunovant, Inc.
27.17
-2.09%
IMCR Immunocore Holdings plc
58.46
+0.79%